Denosumab for bone lesions in multiple myeloma – what is its value?

Daniel A. Goldstein^*

^*Corresponding author for this work

Rabin Medical Center Israel

Research output: Contribution to journal › Comment/debate

15 Scopus citations

Original language	English
Pages (from-to)	753-754
Number of pages	2
Journal	Haematologica
Volume	103
Issue number	5
DOIs	https://doi.org/10.3324/haematol.2017.185264
State	Published - 30 Apr 2018
Externally published	Yes

Access to Document

10.3324/haematol.2017.185264

Other files and links

Link to publication in Scopus

Cite this

@article{4c3754f539d44ff4915e3565312e764a,

title = "Denosumab for bone lesions in multiple myeloma – what is its value?",

author = "Goldstein, \{Daniel A.\}",

year = "2018",

month = apr,

day = "30",

doi = "10.3324/haematol.2017.185264",

language = "אנגלית",

volume = "103",

pages = "753--754",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "5",

}

TY - JOUR

T1 - Denosumab for bone lesions in multiple myeloma – what is its value?

AU - Goldstein, Daniel A.

PY - 2018/4/30

Y1 - 2018/4/30

UR - https://www.scopus.com/pages/publications/85046366072

U2 - 10.3324/haematol.2017.185264

DO - 10.3324/haematol.2017.185264

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 29712820

AN - SCOPUS:85046366072

SN - 0390-6078

VL - 103

SP - 753

EP - 754

JO - Haematologica

JF - Haematologica

IS - 5

ER -